Rekah Pharmaceutical Industry Ltd. (TLV:REKA)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
1,150.00
-45.00 (-3.77%)
Apr 20, 2026, 5:29 PM IDT

TLV:REKA Income Statement

Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
300.99321.71321.66292.39263.95
Revenue Growth (YoY)
-6.44%0.01%10.01%10.78%-0.57%
Cost of Revenue
231.42249.76241.46213.69198.79
Gross Profit
69.5771.9580.278.7165.16
Selling, General & Admin
71.5473.9671.1760.4549.62
Research & Development
4.33.833.653.232.08
Other Operating Expenses
0.981.512.481.770.55
Operating Expenses
76.8179.2977.365.4652.25
Operating Income
-7.25-7.342.9113.2512.91
Interest Expense
-6.41-6.71-8.29-5.65-5.63
Interest & Investment Income
0.370.360.710.040.07
Earnings From Equity Investments
-0.10.01-0.22--0.13
Currency Exchange Gain (Loss)
-0.250.04-0.320.14-0.79
Other Non Operating Income (Expenses)
-0.77-0.77-1.29-0.830.06
EBT Excluding Unusual Items
-14.41-14.4-6.56.966.48
Gain (Loss) on Sale of Investments
-0.01-0.020.02-0.021.19
Gain (Loss) on Sale of Assets
0.1623.710.0500.05
Other Unusual Items
3.06-1.36-0.62-6.59-
Pretax Income
-11.27.93-7.050.367.71
Income Tax Expense
6.881.72-0.142.41.1
Earnings From Continuing Operations
-18.076.21-6.91-2.046.61
Net Income to Company
-18.076.21-6.91-2.046.61
Minority Interest in Earnings
---00.01
Net Income
-18.076.21-6.91-2.046.62
Net Income to Common
-18.076.21-6.91-2.046.62
Net Income Growth
-----38.65%
Shares Outstanding (Basic)
1111111111
Shares Outstanding (Diluted)
1111111111
EPS (Basic)
-1.580.54-0.61-0.180.58
EPS (Diluted)
-1.580.54-0.61-0.180.58
EPS Growth
-----38.65%
Free Cash Flow
5.9217.8516.8632.077.68
Free Cash Flow Per Share
0.521.561.482.810.67
Dividend Per Share
----0.868
Gross Margin
23.11%22.36%24.93%26.92%24.69%
Operating Margin
-2.41%-2.28%0.90%4.53%4.89%
Profit Margin
-6.00%1.93%-2.15%-0.70%2.51%
Free Cash Flow Margin
1.97%5.55%5.24%10.97%2.91%
EBITDA
15.3425.1832.8240.7335.77
EBITDA Margin
5.10%7.83%10.20%13.93%13.55%
D&A For EBITDA
22.5932.5229.9227.4822.86
EBIT
-7.25-7.342.9113.2512.91
EBIT Margin
-2.41%-2.28%0.90%4.53%4.89%
Effective Tax Rate
-21.72%-672.27%14.21%
Advertising Expenses
3.462.513.161.31.63
Source: S&P Global Market Intelligence. Standard template. Financial Sources.